Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levodopa toxicity and apoptosis

E Melamed1, D Offen, A Shirvan

  • 1Department of Neurology, Rabin Medical Center, Felsenstein Research Institute, Petah Tikva, Israel.

Annals of Neurology
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical course and prognostic disparities of pyoderma gangrenosum based on underlying disease: A long-term comparative study in 124 patients.

Annales de dermatologie et de venereologie·2025
Same author

Exploring Remission Dynamics and Prognostic Factors in Lichen Planopilaris: A Retrospective Cohort Study.

Dermatology (Basel, Switzerland)·2024
Same author

Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study.

Mycoses·2023
Same author

Percutaneous ethanol sclerotherapy is a promising treatment for recalcitrant angiolymphoid hyperplasia with eosinophilia.

Clinical and experimental dermatology·2021
Same author

Agminated benign vascular tumour successfully treated with trametinib.

The British journal of dermatology·2021
Same author

Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B.

Molecular autism·2020
Same journal

Sex Differences in the Association of Simultaneous Decline in Blood Pressure and Decline in Cognition during Aging.

Annals of neurology·2026
Same journal

Neurophysiological Recovery Following Nerve Transfer Surgery to Restore Upper Limb Function after Cervical Spinal Cord Injury.

Annals of neurology·2026
Same journal

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

Annals of neurology·2026
Same journal

Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.

Annals of neurology·2026
Same journal

AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis.

Annals of neurology·2026
Same journal

Five Issues of Artificial Intelligence in Science: Sailing the Ship of Theseus.

Annals of neurology·2026
See all related articles

Levodopa is toxic to cells in lab studies, causing cell death through apoptosis. However, this levodopa toxicity is not observed in living organisms, suggesting it may be safe for Parkinson's disease treatment.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Levodopa (L-DOPA) exhibits significant toxicity to cultured neuronal and non-neuronal cells in vitro.
  • This in vitro levodopa toxicity is primarily attributed to its auto-oxidation, generating reactive oxygen species and quinones.
  • Antioxidants, especially thiol compounds, can mitigate levodopa's toxic effects in cell cultures.

Purpose of the Study:

  • To investigate the discrepancy between levodopa's in vitro toxicity and its in vivo effects.
  • To determine if levodopa induces apoptosis in dopaminergic neurons in vivo, particularly in the context of Parkinson's disease.

Main Methods:

  • Review of in vitro studies detailing levodopa's cellular toxicity mechanisms.
  • Examination of evidence regarding levodopa's effects on nigrostriatal dopaminergic neurons in vivo.

Related Experiment Videos

  • Assessment of apoptosis occurrence in the substantia nigra of Parkinson's disease patients.

    • Main Results:

    • Levodopa triggers apoptosis in vitro, characterized by cell shrinkage, membrane blebbing, and DNA fragmentation.
    • No evidence suggests levodopa damages nigrostriatal dopaminergic neurons in vivo in animal models or Parkinson's disease patients.
    • While apoptosis occurs in the parkinsonian substantia nigra, levodopa's role in inducing or accelerating this process in residual neurons remains unknown.

    Conclusions:

    • Levodopa's potent in vitro toxicity does not translate to in vivo neurotoxicity in experimental models or Parkinson's disease patients.
    • The mechanisms of levodopa-induced cell death in vitro differ from the pathological processes in the Parkinson's disease brain.
    • Further research is needed to clarify levodopa's precise role, if any, in the programmed cell death of nigral neurons in Parkinson's disease.